Furthermore, inhibition of the STAT/Ten-eleven translocation 1 axis can be used as a tantalizing therapeutic target in AML by regulating the Janus Associated Kinase (JAK)–STAT signaling [18,19]. This evidence concerns the gene SOAT1 and acute myeloid leukemia.